Splenic and immune alterations of the Sparc-null mouse accompany a lack of immune response
- 8 March 2007
- journal article
- Published by Springer Nature in Genes & Immunity
- Vol. 8 (3) , 262-274
- https://doi.org/10.1038/sj.gene.6364388
Abstract
Sparc-null mice have been used as models to assess tumor-host immune cell interactions. However, it is not known if they have a competent immune system. In this study, the immune systems of Sparc wild-type and null mice were compared. Mice were assessed for differences in total body weight, spleen weight and spleen-to-body weight ratios. Spleens were compared with respect to morphology, and Sparc, Ki-67, MOMA-1 and IgM expression. Immune cells in blood, bone marrow and spleen were assessed by blood smears, automated blood panel, and flow cytometry. Additionally, the ability of Sparc-null mice to respond to immune challenge was evaluated using a footpad model. The morphological and immunohistochemical results indicated that Sparc-null spleens had more white pulp, hyperproliferative B cells in the germinal centers, and decreased marginal zones. Sparc-null spleens lacked normal Sparc expression in red and white pulp, marginal zones, endothelial and sinusoidal cells. By flow analysis, B cells were decreased and T cells were increased in the bone marrow. Finally, Sparc-null mice were unable to mount an immune response following footpad lipopolysaccharide challenge. These data confirm that Sparc-null mice have an impaired immune system.Keywords
This publication has 32 references indexed in Scilit:
- Stabilin-1, a homeostatic scavenger receptor with multiple functionsJournal of Cellular and Molecular Medicine, 2006
- Absence of Host-Secreted Protein Acidic and Rich in Cysteine (SPARC) Augments Peritoneal Ovarian CarcinomatosisThe American Journal of Pathology, 2005
- Parietal endoderm secreted SPARC promotes early cardiomyogenesis in vitroExperimental Cell Research, 2005
- Accelerated dendritic-cell migration and T-cell priming in SPARC-deficient miceJournal of Cell Science, 2005
- MARGINAL ZONE B CELLSAnnual Review of Immunology, 2005
- Neuroblastoma Angiogenesis Is Inhibited with a Folded Synthetic Molecule Corresponding to the Epidermal Growth Factor-Like Module of the Follistatin Domain of SPARCCancer Research, 2004
- Development of UV-Induced Squamous Cell Carcinomas Is Suppressed in the Absence of SPARCJournal of Investigative Dermatology, 2004
- International hermelin brain tumor symposium on matricellular proteins in normal and cancer cell-matrix interactionsMatrix Biology, 2004
- Leukocyte, Rather than Tumor-produced SPARC, Determines Stroma and Collagen Type IV Deposition in Mammary CarcinomaThe Journal of Experimental Medicine, 2003
- SPARC (Secreted Protein Acidic and Rich in Cysteine) Induces Apoptosis in Ovarian Cancer CellsThe American Journal of Pathology, 2001